Clinical trial
Adherence to Artemisinin-Based Combination Therapy (ACT) for the Treatment of Malaria in Sierra Leone
NCT01967472 is registered in ClinicalTrials.gov with London School of Hygiene and Tropical Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adherence to Artemisinin-Based Combination Therapy (ACT) for the Treatment of Malaria in Sierra Leone
- Lead sponsor
- London School of Hygiene and Tropical Medicine
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 16, 2013
- Completion date
- January 31, 2014
- Enrollment
- 1,145 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.